NCT04015817

Brief Summary

Dyspnoea is a very common symptom in many diseases, not only cardiorespiratory, but also renal or neurological diseases. It can be defined as " difficult, laboured and uncomfortable breathing \[…\]. It is a subjective symptom. As pain, it involves both the patient's perception of the sensation and his reaction to it ". It can occur during even moderate effort and sometimes also at rest and tends to increase as the disease causing it progresses. Dyspnoea has therefore a significant on the various aspects of the patient's daily life and those around him or her (travel, leisure, daily activities, etc.) leading to a decrease in quality of life and possibly to anxiety and/or depressive symptoms. Among a vulnerable, elderly population that benefits from home care, it affects more than 46 % of patients in north-west of Switzerland. Despite the handicap generated by daily dyspnoea, this complaint is often difficult to recognize by health professionals or family and friends, due in particular to a feeling of helplessness in the care provided. In addition, the treatment of the disease responsible for dyspnoea by the doctor does not always provide relief. In this context, it is essential that people with dyspnoea, families and friends are supported in their experiences and acquire techniques and alternatives that help them better manage dyspnoea on a daily basis. The first objective is to evaluate the feasibility of a dyspnoea support program led by a respiratory care team non-specialized in palliative care and its effect on quality of life and control of dyspnoea symptoms by patients . A second objective is to measure patient's satisfaction about the program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 11, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

July 6, 2022

Status Verified

June 1, 2022

Enrollment Period

2.4 years

First QC Date

July 1, 2019

Last Update Submit

June 30, 2022

Conditions

Keywords

DyspneaWell beingrespiratory care team non-specialized in palliative care

Outcome Measures

Primary Outcomes (1)

  • Change measured by the Chronic Respiratory Questionnaire (CRQ) between the initial interview (T0) and the progress report in patients with refractory dyspnea

    Minimally important difference is reflected by a change in score of 0.5 on a 7 point scale

    an average of four month

Secondary Outcomes (1)

  • Measure patient satisfaction with the program in the progress report : visual analogic scale

    an average of four month

Study Arms (1)

Etude longitudinale

EXPERIMENTAL

Work on positions, ventilatory education, use of a fan, pulmonary rehabilitation, stress management, mindfulness meditation, psychosocial services, support from the mobile palliative care team

Other: paramedical and non-pharmacological services

Interventions

Paramedical and non-pharmacological services (work on positions, ventilatory education, use of a fan, pulmonary rehabilitation, stress management, mindfulness meditation, psychosocial services, possible support from the mobile palliative care team)

Etude longitudinale

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • refractory breathlessness on exertion or rest (Medical Research Council (MRC) dyspnea scale score ≥2), despite optimum treatment of the underlying disease, as deemed by the responsible physician;
  • advanced disease such as cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, interstitial lung disease or motor neuron disease;
  • willing to engage with proposed therapy (physiotherapy);
  • able to provide informed consent in French.

You may not qualify if:

  • Breathlessness of unknown cause;
  • A primary diagnosis of chronic hyperventilation syndrome;
  • Completely house (or hospital or nursing home) bound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ligue pulmonaire neuchâteloise

Peseux, Canton of Neuchâtel, 2034, Switzerland

Location

Related Publications (8)

  • Booth S, Burkin J, Moffat C, Spathis A. Managing Breathlessness in Clinical Practice. 1st ed. New York : Springer; 2013. 265 p.

    BACKGROUND
  • Comroe, J. Some theories on the mechanism of dyspnea. In: Howell J, Campbell, E. Breathlessness: proceeding of an international symposium on breathlessness. Oxford: Blackwell; 1965.

    BACKGROUND
  • Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, McCrone P, Booth S, Jolley CJ, Moxham J. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014 Dec;2(12):979-87. doi: 10.1016/S2213-2600(14)70226-7. Epub 2014 Oct 29.

    PMID: 25465642BACKGROUND
  • Clark, G, Marechal, M. COPD knowledge in a swiss frail selected population. European respiratory Society Congress 2018

    BACKGROUND
  • Pautex S, Vayne-Bossert P, Bernard M, Beauverd M, Cantin B, Mazzocato C, Thollet C, Bollondi-Pauly C, Ducloux D, Herrmann F, Escher M. Validation of the French Version of the Edmonton Symptom Assessment System. J Pain Symptom Manage. 2017 Nov;54(5):721-726.e1. doi: 10.1016/j.jpainsymman.2017.07.032. Epub 2017 Jul 25.

    PMID: 28751077BACKGROUND
  • Beaumont M, Couturaud F, Jego F, Pichon R, Le Ber C, Peran L, Roge C, Renault D, Narayan S, Reychler G. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire. Int J Chron Obstruct Pulmon Dis. 2018 Apr 30;13:1399-1405. doi: 10.2147/COPD.S145048. eCollection 2018.

    PMID: 29750026BACKGROUND
  • Bocerean C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. 2014 Dec 16;14:354. doi: 10.1186/s12888-014-0354-0.

    PMID: 25511175BACKGROUND
  • Bourbeau J, Maltais F, Rouleau M, Guimont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J. 2004 Oct;11(7):480-6. doi: 10.1155/2004/702421.

    PMID: 15505701BACKGROUND

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jean-Marc Fellrath, Prof

    Hopital Neuchatelois

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2019

First Posted

July 11, 2019

Study Start

August 1, 2019

Primary Completion

January 1, 2022

Study Completion

June 1, 2022

Last Updated

July 6, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

There are no plans to share the data collected with other researchers.

Locations